HOME › DRUGS › ICATIBANT
ACTIVE SUBSTANCE / INN

ICATIBANT

Brand name(s): Firazyr, Icatibant Accord
EMA LISTED
AUTHORISED
Angioedemas, Hereditary
ACTIVE SUBSTANCE
Icatibant
REGULATORS
EMA
SPONSORS / MAH
Accord Healthcare S.L.U., Takeda Pharmaceuticals International AG
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FirazyrTakeda Pharmaceuticals International AGAuthorised11/07/2008Angioedemas, Hereditary
Icatibant AccordAccord Healthcare S.L.U.Authorised16/07/2021Angioedemas, Hereditary

FULL INTELLIGENCE ON ICATIBANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →